RECOMBINATE 500 IU

Страна: Израел

Език: английски

Източник: Ministry of Health

Активна съставка:

COAGULATION FACTOR VIII RECOMBINANT 500 IU/VIAL

Предлага се от:

TEVA MEDICAL MARKETING LTD.

АТС код:

B02BD05

Лекарствена форма:

POWDER FOR SOLUTION FOR INJECTION

Начин на приложение:

I.V

Произведено от:

BAXTER S.A., BELGIUM

Терапевтична група:

COAGULATION FACTOR VII

Терапевтични показания:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Дата Оторизация:

2010-07-01